Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters











Database
Language
Publication year range
1.
J Pharm Pharmacol ; 73(12): 1617-1629, 2021 Dec 07.
Article in English | MEDLINE | ID: mdl-34718677

ABSTRACT

OBJECTIVES: This study aimed to discover the active compounds of Sophora flavescens Ait. (SF), the anti-itch effects and underlying mechanisms of oxymatrine (OMT), one of the bioactive compounds from SF. METHODS: Dorsal root ganglion cell membrane immobilized chromatography was used to screen potential anti-pruritic active compounds from SF. The scratching behaviour was analysed to systematically study the anti-pruritic effects of OMT in chloroquine- (CQ), peptide Ser-Leu-Ile-Gly-Arg-Leu- (SLIGRL), histamine- (HIS) and allyl-isothiocyanate-(AITC)-induced itch mice models. Real-time quantitative PCR, in-vivo study and molecular docking were employed to explore the underlying mechanisms. KEY FINDINGS: All in all, 21 compounds of SF were identified and 5 potential bioactive compounds were discovered. OMT significantly reduced scratching bouts in two HIS-independent itch models induced by CQ and SLIGRL but was not effective in the HIS-induced itch model. OMT reduced scratching bouts in a dose-dependent manner and decreased the messenger RNA (mRNA) expression of transient receptor potential ankyrin 1 (TRPA1) channel in two HIS-independent itch models; in addition, OMT reduced the wipes and scratching bouts induced by AITC. CONCLUSIONS: This study discovered five potential anti-pruritic compounds including OMT in the SF extract, and OMT has strong anti-pruritic effects in HIS-independent itch via TRPA1 channel.


Subject(s)
Alkaloids/therapeutic use , Antipruritics/therapeutic use , Phytotherapy , Plant Extracts/therapeutic use , Pruritus/drug therapy , Quinolizines/therapeutic use , Sophora/chemistry , TRPA1 Cation Channel/metabolism , Alkaloids/pharmacology , Animals , Antipruritics/pharmacology , Cell Membrane , Chloroquine , Chromatography/methods , Disease Models, Animal , Drug Discovery/methods , Ganglia, Spinal , Histamine , Humans , Isothiocyanates , Male , Mice, Inbred C57BL , Molecular Docking Simulation , Oligopeptides , Plant Extracts/pharmacology , Pruritus/chemically induced , Quinolizines/pharmacology , RNA, Messenger/metabolism
2.
Opt Express ; 29(12): 18705-18719, 2021 Jun 07.
Article in English | MEDLINE | ID: mdl-34154121

ABSTRACT

Dimensions of the edge-lit light guide plate (LGP) have a non-negligible impact on its output performance based on a pre-determined micro-dot array. However, how the LGP's dimension affects the performance has not been systematically researched. In this paper, the dimension of the LGP is numerically established as a function to the light output performance, which can be divided into four successive procedures. Firstly, the micro-structural dot array is designed based on the calculated illuminance distribution of the LGP's bottom surface. Based on this, the light energy output can be derived by defining three key parameters, which are dot density, scatting coefficient, and collision loss coefficient. After that, the ray-tracing simulation is used to determine the above parameters. Finally, the optimal dimensions of the LGP can be obtained with a specific correlation function with the light energy output. The mathematical relation above is demonstrated via both simulation and experiment. Our approach provides a systematic design for balancing the efficiency and uniformity of backlight by combining the dot design and the dimensional optimization, which has important theoretical guiding significance for actual display application.

3.
J Phys Chem Lett ; 11(19): 8442-8450, 2020 Oct 01.
Article in English | MEDLINE | ID: mdl-32940472

ABSTRACT

Multinozzle printing processing with the fabrication of a functional material film lays the foundation for the development of efficient scale production of a photoelectric device. However, a prominent challenge is how to realize the volume uniformity of the droplets. Here, a classical analysis method is introduced first by printing poly(3,4-ethylenedioxythiophene)/poly(styrenesulfonate) (PEDOT:PSS) to analyze the behavior of droplets. It relies on a variance calculation for the clarification of the law of implicit behavior of droplets in terms of digitizing. This method reveals the effect of printing parameters on the uniformity of the volume of droplets in multinozzle printing. Overall, by combining both ink formulations and printing parameter optimization, it is concluded that the minimum volume variance of nozzles with different numbers is less than 0.5% and the influence of various parameters in multinozzle printing is found to be ranked. The feasibility of this analysis method is presented and is of great significance to achieving a very stable, large-scale multinozzle printing device.

4.
Pain Rep ; 4(5): e781, 2019.
Article in English | MEDLINE | ID: mdl-31875186

ABSTRACT

INTRODUCTION: Irritant contact dermatitis (ICD) and allergic contact dermatitis (ACD) are inflammatory skin diseases accompanied by itch and pain. Irritant contact dermatitis is caused by chemical irritants eliciting an innate immune response, whereas ACD is induced by haptens additionally activating an adaptive immune response: After initial exposure (sensitization) to the hapten, a subsequent challenge can lead to a delayed-type hypersensitivity reaction. But, the sensory and inflammatory effects of sensitization (ICD) vs challenge of ACD are insufficiently studied. Therefore, we compared itch- and pain-like behaviors and inflammatory reactions evoked in mice during the sensitization (ICD) vs challenge phase (ACD) of application of the hapten, squaric acid dibutylester (SADBE). OBJECTIVES: Our aim was to compare itch- and pain-like behaviors and inflammatory reactions evoked in mice during the sensitization (ICD) vs challenge phase (ACD) of application of the hapten, squaric acid dibutylester (SADBE). METHODS: Mice were sensitized on the abdomen with 1% SADBE (ACD) or vehicle treated (ICD, control). Spontaneous and stimulus-evoked itch- and pain-like behaviors were recorded in mice before and after 3 daily challenges of the cheek with 1% SADBE (ACD, ICD). Cutaneous inflammation was evaluated with clinical scoring, ultrasound imaging, skin thickness, histology, and analyses of selected biomarkers for contact dermatitis, IL-1ß, TNF-α, CXCL10, and CXCR3. RESULTS: Allergic contact dermatitis vs ICD mice exhibited more spontaneous site-directed scratching (itch) and wiping (pain). Allergic contact dermatitis-but not ICD-mice exhibited allodynia and hyperalgesia to mechanical and heat stimuli. Inflammatory mediators IL-1ß and TNF-α were upregulated in both groups as well as the chemokine receptor, CXCR3. CXCL10, a CXCR3 ligand, was upregulated only for ACD. Inflammatory responses were more pronounced in ACD than ICD. CONCLUSION: These findings provide new information for differentiating the behavioral and inflammatory reactions to hapten-induced ICD and ACD.

5.
J Dermatol Sci ; 2018 May 31.
Article in English | MEDLINE | ID: mdl-29903654

ABSTRACT

BACKGROUND: Allergic contact dermatitis (ACD) is a highly prevalent inflammatory disease of the skin. As a result of the complex etiology in ACD, therapeutic compounds targeting refractory pruritus in ACD lack efficacy and lead to numerous side effects. OBJECTIVE: In this study, we investigated the anti-pruritic effects of oxymatrine (OMT) and explored its mechanism of action in a mouse model of ACD. METHOD: 72 male SPF C57BL/6 mice were randomly divided into control group, ACD model group, dexamethasone positive control group (0.08 mg kg-1) and 3 OMT groups (80, 40, 20 mg kg-1). OMT was administrated by intraperitoneal injection 1 h before video recording on day 10, 24 h after 2nd challenge with SADBE. Cheek skin fold thickness was measured before treatment and after recording. H&E staining was used for pathological observation. RT-qPCR, Immunohistochemistry and LEGENDplexTM assay were used to detect cytokines levels. The population of Treg cells in peripheral blood were detected via flow cytometry. RESULTS: OMT treatment significantly decreases the skin inflammation and scratching bouts. It rescues defects in epidermal keratinization and inflammatory cell infiltration in ACD mice. Administration of OMT significantly reduced levels of IFN-γ, IL-13, IL-17A, TNF-α, IL-22 and mRNA expression of TNF-α and IL-1ß. Furthermore, it increased the percentage of Treg cells in peripheral blood of ACD mice. CONCLUSION: We have demonstrated that OMT exhibits anti-pruritic and anti-inflammatory effects in ACD mice by regulating inflammatory mediators. OMT might emerge as a potential drug for the treatment of pruritus and skin inflammation in the setting of ACD.

6.
J Ethnopharmacol ; 195: 118-126, 2017 Jan 04.
Article in English | MEDLINE | ID: mdl-27880884

ABSTRACT

ETHNOPHARMACOLOGICAL RELEVANCE: The Angong Niuhuang Pill (ANP) is a well known Chinese traditional therapeutic for the treatment for diseases affecting the Central Nervous System (CNS). Components of the ANP formulation, including Bovis Calculus Sativus, Pulvis Bubali Comus Concentratus, Moschus, Margarita, Cinnabaris, Realgar, Coptidis Rhizoma, Scutellariae Radix, Gardeniae Fructus, Curcumae Radix, and Bomeolum Syntheticum, have been used for the treatment of stroke, encephalitis and emergency meningitis across Asia, especially in China for hundreds of years. OBJECTIVE: The goal of this study was to investigate the anti-atherosclerosis and cardio-protective effects of ANP administration using a rodent model of atherosclerosis induced by a high fat and vitamin D3. METHODS: Specific Pathogen-Free (SPF) 78 male SD rats were randomly divided into a control group and 5 atherosclerotic model groups. The atherosclerotic groups were divided to receive either Simvastatin (SVTT, 0.005g/kg), Low-dose ANP (0.125g/kg), Medium-dose ANP (0.25g/kg), and High-dose ANP (0.5g/kg). Following adaptive feeding for one week, atherosclerosis was induced and the atherosclerosis model was established. Experimental drugs (either simvastatin or ANP) or normal saline were administered intragastrically once daily for 9 weeks starting from the 8th week. A carotid artery ultrasound was performed at the 17th week to determine whether atherosclerosis had been induced. After the atherosclerosis model was successfully established, platelet aggregation rates, serum biochemical indices, apoptosis-related Bcl-2, Bax proteins levels in the heart were assayed. Pathological and histological analysis was completed using artery tissue from different experimental different groups to assess the effects of ANP. RESULTS: ANP significantly decreased aortic membrane thickness, the maximum platelet aggregation rates, and the ratio of low density lipoprotein cholesterol (LDL) to high density lipoprotein cholesterol (HDL). In addition, ANP significantly reduced serum contents of total cholesterol, low density lipoprotein, malondialdehyde, troponin I, high-sensitivity C-reactive protein, and lactate dehydrogenase. ANP markedly improved abnormal pathological conditions of the aorta and heart, and helped to prevent myocardial apoptosis. CONCLUSIONS: We have demonstrated that ANP has robust ant-atherosclerosis and cardio-protective effects on a high-fat and vitamin D3 - induced rodent model of atherosclerosis due to its antiplatelet aggregation, lipid regulatory, antioxidant, anti-inflammatory and anti-apoptotic properties.


Subject(s)
Aortic Diseases/prevention & control , Atherosclerosis/prevention & control , Carotid Artery Diseases/prevention & control , Cholecalciferol , Diet, High-Fat , Drugs, Chinese Herbal/pharmacology , Hypolipidemic Agents/pharmacology , Animals , Anti-Inflammatory Agents/pharmacology , Antioxidants/pharmacology , Aorta, Thoracic/drug effects , Aorta, Thoracic/metabolism , Aorta, Thoracic/ultrastructure , Aortic Diseases/blood , Aortic Diseases/chemically induced , Aortic Diseases/diagnostic imaging , Apoptosis/drug effects , Atherosclerosis/blood , Atherosclerosis/chemically induced , Atherosclerosis/diagnostic imaging , Biomarkers/blood , Carotid Artery Diseases/blood , Carotid Artery Diseases/chemically induced , Carotid Artery Diseases/diagnostic imaging , Disease Models, Animal , Enzymes/blood , Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacology , Inflammation Mediators/blood , Lipids/blood , Male , Myocardium/pathology , Platelet Aggregation/drug effects , Platelet Aggregation Inhibitors/pharmacology , Rats, Sprague-Dawley , Simvastatin/pharmacology , Tablets , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL